Related Experiment Video

Updated: May 4, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K

Post-implantation transcatheter aortic valve migration in a left ventricular assist device patient with severe aortic

Boon-Hean Ong1, Paul T L Chiam2, David K L Sim3

  • 1Department of Cardiothoracic Surgery, National Heart Centre Singapore, Mistri Wing, 17 Third Hospital Avenue, Singapore, Singapore;

European Heart Journal
|December 17, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

722
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K

Related Experiment Videos

Last Updated: May 4, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

722
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Genomic and transcriptomic landscape of spread through air spaces in stage 1 lung adenocarcinoma.

British journal of cancer·2026

Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Early EGFR Inhibition Triggers Actionable Tumor and Microenvironmental Remodeling in Lung Cancer.

Cancer research communications·2026

Pleural-Based GLI1-Altered Mesenchymal Tumor With ACTB-GLI1 Fusion: A Rare Pulmonary Entity Mimicking Synovial Sarcoma.

Thoracic cancer·2026

Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE Study.

JTO clinical and research reports·2026

EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2025

Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.

European heart journal·2026

Targeting trafficking defects in long QT syndrome type 2: a phase 2 clinical study with patient-specific cellular validation.

European heart journal·2026

Intracranial haemorrhage following tenecteplase fibrinolysis for acute myocardial infarction.

European heart journal·2026

Laparoscopic repair of iatrogenic diaphragmatic hernia following pedicled omentoplasty using a modified Sugarbaker technique with round ligament reinforcement.

Journal of surgical case reports·2026

Novel HIV fusion-inhibitory lipopeptides exhibit dramatically improved activity against resistant mutants.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Hormonal Activity of 3D Bioprinting Materials Using the E-Screen and PALM Bioassays.

Toxics·2026

Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer.

Pharmaceuticals (Basel, Switzerland)·2026

Cycloastragenol Attenuates Angiotensin II-Induced Cardiac Remodeling in Association with Enhanced EGFR Lysosomal Turnover and Changes in MAPK Signaling and Autophagy.

Pharmaceuticals (Basel, Switzerland)·2026

Comparative Analysis of In Vitro Permeation and Human Pharmacokinetic Data for a Bioadhesive Vaginal Tablet as a Potential Clinical Approach for Bacterial Vaginosis.

Pharmaceutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us